New Treatments Emerging for Migraine Sufferers
A canceled dinner, another missed workday, an afternoon spent waiting for the room to stop feeling too bright and too loud. For people living with migraine, the impact reaches far beyond head pain. And when familiar medications offer little relief, it’s easy to assume that managing the condition means simply enduring it. Fortunately, migraine treatment has changed considerably in recent years. Medicines developed specifically for migraine, along with devices and other approaches, are giving patients more options to discuss with their doctors.
Dr. Crystal Jicha, a UCI Health neurologist who specializes in migraine and other headache disorders, emphasizes that getting the right diagnosis is an essential starting point. Migraine is a neurological condition, and recognizing its symptoms can help people receive appropriate care.
A tension headache commonly feels like pressure or a tight band around the head. Migraine attacks can bring pain severe enough to interrupt ordinary activities, often accompanied by nausea, vomiting, or sensitivity to light and sound. Some people also find smells difficult to tolerate.
Others experience an aura: temporary neurological symptoms that may include shimmering lines, blind spots, or tingling sensations. Not everyone with migraine experiences aura, and symptoms can vary between people and even between attacks. There is no single blood test or brain scan that confirms migraine. Doctors generally make the diagnosis through a medical history, symptom assessment, and examination, ordering tests when needed to investigate other causes.
One of the biggest changes in treatment has come from understanding a substance called calcitonin gene-related peptide, or CGRP. This naturally occurring chemical messenger plays a role in the pain pathways involved in migraine. Newer medications target either CGRP itself or the receptor it acts on, helping interrupt those signals.
For years, many preventive treatments came from medicines originally developed for other conditions, including certain blood-pressure medicines, antidepressants, and antiseizure drugs. Those treatments can still be useful. CGRP therapies have expanded the choices by offering medications designed specifically around migraine biology.
There are two different treatment goals to understand:
Acute treatment is used to relieve an attack when it occurs.
Preventive treatment is taken on a schedule to reduce how often attacks happen and, in some cases, how severe they are.
Depending on the medication, CGRP treatments come as tablets, injections, intravenous infusions, or a nasal spray. Some treat attacks, some prevent them, and certain medicines can serve either purpose under an appropriate prescribing plan. The formulation and schedule depend on the particular drug.
The American Headache Society considers CGRP therapies a first-line option for migraine prevention. That means patients do not necessarily need to try and fail older preventive medicines before these treatments can be considered medically appropriate. However, a professional recommendation does not guarantee insurance coverage. Individual plans may still impose requirements or restrictions.
These medicines are not the answer for everyone. Benefits, side effects, other health conditions, medication interactions, cost, and personal preferences all matter when choosing treatment. Someone who dislikes daily tablets may prefer a less frequent treatment, while another person may strongly prefer an oral medicine.
Medication is also only one part of migraine care. Devices that use electrical or magnetic stimulation to influence nerve pathways offer another option. Known as neuromodulation devices, they may help treat attacks, prevent them, or both, depending on the device. Some require a prescription, and availability, suitability, and insurance coverage vary.
Regular sleep, adequate hydration, consistent meals, and stress-management techniques can also support treatment. Cognitive behavioral therapy and mindfulness may help some people manage symptoms and the burden of living with recurring attacks. These approaches do not imply that migraine is imagined or simply caused by stress; they are additional ways to manage a complex neurological condition.
A headache diary can make appointments more useful. There’s no need for an elaborate system: a notebook, calendar, or phone app can work. Record when symptoms occur, how long they last, how disruptive they are, which treatments you use, and whether those treatments help. Note possible contributing factors, such as disrupted sleep or missed meals, without assuming that every attack must have an identifiable trigger.
You do not have to wait until migraine takes over your life to ask for help.
Recurring attacks that interfere with work, family responsibilities, or social activities deserve medical attention. So do symptoms that persist despite treatment. A primary care clinician can assess the problem and, when appropriate, refer you to a neurologist or headache specialist.
Researchers are also investigating treatments beyond CGRP. One promising target is another signaling molecule called PACAP. Experimental medicines that block this pathway have shown encouraging results in clinical trials, but they remain under investigation. More research is needed to establish their benefits, risks, and eventual place in migraine care.
There is still no cure for migraine, and finding an effective treatment can take patience. But an unsuccessful treatment years ago does not mean today’s options will offer the same result. If your current approach leaves you regularly missing out on everyday life, a fresh conversation with your doctor may reveal possibilities you haven’t yet tried.